Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
Subscribe To Our Newsletter & Stay Updated
